Evaluation of PPP2R5C gene expression in Iranian patients with B-Acute lymphoblastic leukemia and its association with clinical and laboratory findings

Introduction: PPP2R5C is one of the regulatory B subunits of protein phosphatase 2A (PP2A), which is a tumor suppressor. PPP2R5C plays a critical role in cell proliferation, differentiation, and transformation. Considering these vital functions, we investigate the gene expression in Iranian patients with B-Acute Lymphoblastic Leukemia (B-ALL) and its association with clinical and laboratory finding. Materials and methods: In this case-control study, peripheral blood samples were collected from 60 B-ALL patients and 30 healthy controls. PPP2R5C expression levels were determined by Real-time PCR. After calculation of CT for target and control genes, we calculated ΔCT. Finally we compared the PPP2R5C expression levels in patients with control group. Results: Significantly higher expression of PPP2R5C was found in the B-ALL patients (2.15±2. 50) compared with control group. There was no correlation between PPP2R5C expression and clinical and laboratory findings and FAB (French-American-British) subtype of patients. Conclusion: we demonstrated PPP2R5C overexpression in B-ALL patients. Although there was no significant correlation between PPP2R5C expression, clinical and laboratory finding and also with FAB subtypes of patients.

[1]  M. Konopleva,et al.  New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia , 2015, Cancer.

[2]  N. Rahman,et al.  Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth , 2015, Human molecular genetics.

[3]  Shaohua Chen,et al.  Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells. , 2013, DNA and cell biology.

[4]  Shaohua Chen,et al.  Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation , 2013, Journal of Hematology & Oncology.

[5]  Shaohua Chen,et al.  Expression and distribution of PPP2R5C gene in leukemia , 2011, Journal of hematology & oncology.

[6]  C. Phiel,et al.  Functions of B56-containing PP2As in major developmental and cancer signaling pathways. , 2010, Life sciences.

[7]  A. Kohlmann,et al.  Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignancies. , 2010, Cancer treatment reviews.

[8]  Cheng-Wei Wu,et al.  The B56γ3 Regulatory Subunit of Protein Phosphatase 2A (PP2A) Regulates S Phase-specific Nuclear Accumulation of PP2A and the G1 to S Transition* , 2010, The Journal of Biological Chemistry.

[9]  Xuan Liu,et al.  A B56γ mutation in lung cancer disrupts the p53-dependent tumor suppressor function of protein phosphatase 2A , 2010, Oncogene.

[10]  X. Chen,et al.  PR55α, a Regulatory Subunit of PP2A, Specifically Regulates PP2A-mediated β-Catenin Dephosphorylation , 2009, The Journal of Biological Chemistry.

[11]  H. Helenius,et al.  Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia , 2008, European journal of haematology.

[12]  Xin Cai,et al.  Serine 15 phosphorylation of p53 directs its interaction with B56gamma and the tumor suppressor activity of B56gamma-specific protein phosphatase 2A. , 2008, Molecular and cellular biology.

[13]  Xin Cai,et al.  A specific PP2A regulatory subunit, B56γ, mediates DNA damage‐induced dephosphorylation of p53 at Thr55 , 2007, The EMBO journal.

[14]  D. Perrotti,et al.  ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia , 2006, British Journal of Cancer.

[15]  H. Tagawa,et al.  Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. , 2006, Blood.

[16]  W. Hahn,et al.  Involvement of PP2A in viral and cellular transformation , 2005, Oncogene.

[17]  G. Gahrton,et al.  Identification of progression markers in B-CLL by gene expression profiling. , 2005, Experimental hematology.

[18]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[19]  Joseph R. Nevins,et al.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells , 2004, Nature Cell Biology.

[20]  W. Hahn,et al.  Identification of specific PP2A complexes involved in human cell transformation. , 2004, Cancer cell.

[21]  A. Zeiher,et al.  Regulation of telomerase activity and anti‐apoptotic function by protein–protein interaction and phosphorylation , 2003, FEBS letters.

[22]  J. Minna,et al.  Genomic Organization and Mapping of the Gene Encoding the PP2A B56γ Regulatory Subunit , 2002 .